Navigation Links
Three Penn State research pioneers among first Golden Goose honorees
Date:9/13/2012

Three Penn State scientists have received national honors for their pioneering research, begun more than 40 years ago, that led to the development of implant materials widely used today in human bone and joint repairs. Della Roy, Eugene W. White, and the late Jon N. Weber were among eight researchers nationwide recognized with the newly created Golden Goose award, sponsored by American Association of Universities and other educational and scientific organizations.

The Golden Goose Award demonstrates the human and economic benefits of federally funded research by highlighting examples of seemingly obscure studies that have led to major breakthroughs and benefited society in significant ways. The name of the award is based on the fable about the goose that laid golden eggs.

"Penn State conducts more than $800 million in annual research, providing thousands of jobs across the Commonwealth," said Henry C. "Hank"

Foley, vice president for research and dean of the graduate school. "Seeing this recognition for the positive impact on countless lives that a handful of those faculty have had over decades is exciting. This kind of impact is occurring every day through the work of our world class faculty and researchers."

In the early 1970s, White and Weber discovered that certain types of South Pacific coral had the same porous, interconnected microstructure as human bone. The discovery's importance was based on the fact that the human body often detects the foreign origin of implants, sometimes rejecting them outright, but never fully integrating them. A material was needed that encouraged natural tissue to grow into it, locking it in place and forming a protective layer.

Weber, a marine geologist, had a piece of coral scanned at Penn State's Materials Research Laboratory. Materials scientist White happened to see it and noticed its mazelike pore structure -- the same kind of extremely small, interconnected pore structure that might encourage natural tissue growth.

Since natural corals themselves are too brittle to implant, White, Weber and Rodney White, then a medical student at the State University of New York at Syracuse, used them as molds to make replicas. The coral was machined to the desired shape and impregnated with wax. The coral was then dissolved, yielding a wax "negative," which was then infused with ceramic material -- which materials scientist Roy helped to develop -- yielding a prosthetic that had the intricate porosity of natural bone.

Meanwhile, in related research, Roy perfected a process for "pressure-cooking" coral in a vessel containing a phosphate solution. Phosphate replaced the carbonate in the coral, giving it many of the chemical and mechanical properties of human bone and almost eliminating the probability of rejection. While not as strong as metal implants made via the wax method, the processed coral could be machined to the desired shape and worked well as a material for pins, screws and other hardware in low-stress bone and joint repairs.

These methods of producing bone replacement materials were patented and licensed, and have since been widely adopted. The federally funded research conducted by Roy, White and Weber enabled major advances in implant surgery and dramatically improved the quality of life for countless thousands of people.

Roy is currently professor emerita of materials science. Eugene White left the University in 1977. Weber died in 1976.


'/>"/>

Contact: Michael Bezilla
mxb13@psu.edu
814-865-9481
Penn State
Source:Eurekalert

Related medicine news :

1. Three Kids Dead From Codeine After Surgery: FDA
2. Symposium on sustainability to feature three new NJIT faculty
3. Study reveals how cancer drug causes diabetic-like state
4. New drug prevents spread of human prostate cancer cells
5. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
6. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
7. Study examines adverse effects among different radiation therapies for prostate cancer
8. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
9. Warren Buffett Has Early Stage Prostate Cancer
10. Majority of states fail to address youth exposure to alcohol marketing
11. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... March 30, 2017 , ... MAP ... the risk of relapse in people with addiction who are served by MAP’s ... in the market through empowering patients to stay connected with their entire support ...
(Date:3/30/2017)... (PRWEB) , ... March 30, 2017 , ... Although many ... concerns, equally as many are wary of baring their skin for other reasons, including ... at West Dermatology can help get the skin prepared for the summer weather and ...
(Date:3/30/2017)... , ... March 30, 2017 , ... A new ... that following joint replacement surgery – the best place for a patient to recover ... they are in familiar surroundings and have ample opportunity to rest and recover naturally,” ...
(Date:3/30/2017)... ... 2017 , ... According to the American Society of Plastic Surgeons (ASPS), over ... top 5 most popular minimally-invasive cosmetic procedures in the country. With summer close, it’s ... the next 8-10 weeks. For anyone considering a hair removal procedure, there are a ...
(Date:3/30/2017)... ... March 30, 2017 , ... ... its educational offerings of corporate finance programs to address the increasingly complex educational ... help executives increase their knowledge of sophisticated corporate finance and will increase their ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... -- P rogressed to commercial ... Vergenix™STR distribution and sales agreements in Europe ... 3D bioInk , the Company , s ... for 3D printing of human organs and tissue   P ... in specific indications in 2017   CollPlant (TASE: ...
(Date:3/30/2017)... 30, 2017  Boston Scientific Corporation (NYSE: ... Symetis SA, a privately-held Swiss structural heart company focused ... million in up-front cash. The Symetis portfolio includes ... * systems for use in the treatment of ... stenosis, which are sold in Europe ...
(Date:3/30/2017)... , March 30, 2017 Stock-Callers.com ... in the research, development, and production of non-electronic medical, surgical, ... are: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Co. (NYSE: ... Inc. (NYSE: BCR ). Download the free research ... ...
Breaking Medicine Technology: